New Parenteral Anticoagulants: Focus on Factor Xa and Thrombin Inhibitors

By  

Current Drug Discovery Technologies, Vol. 9, Iss. 2, 2012-06 ,pp. : 129-136

Bentham Science Publishers

Access to resources Recommend Favorite

Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban

By Apostolakis Stavros   Lip Gregory YH  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 1057-1064

Informa Healthcare

Access to resources Recommend Favorite

Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development

By Eriksson Bengt I.  

Clinical Pharmacokinetics, Vol. 48, Iss. 1, 2009-01 ,pp. : 1-22

Adis International

Access to resources Recommend Favorite

Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis

By Sinha U.   Ku P.   Malinowski J.   Zhu B.Y.   Scarborough R.M.   Marlowe C.K.   Wong P.W.   Lin P.H.   Hollenbach S.J.  

European Journal of Pharmacology, Vol. 395, Iss. 1, 2000-04 ,pp. : 51-59

Elsevier

Access to resources Recommend Favorite

Prevention and Treatment of Venous Thromboembolism and Pulmonary Embolism: The Role of Novel Oral Anticoagulants

By  

Current Clinical Pharmacology, Vol. 7, Iss. 3, 2012-08 ,pp. : 175-194

Bentham Science Publishers

Access to resources Recommend Favorite